202 related articles for article (PubMed ID: 4006373)
1. Cefotaxime and desacetyl cefotaxime kinetics in renal impairment.
Matzke GR; Abraham PA; Halstenson CE; Keane WF
Clin Pharmacol Ther; 1985 Jul; 38(1):31-6. PubMed ID: 4006373
[TBL] [Abstract][Full Text] [Related]
2. Cefmenoxime pharmacokinetics in patients with renal insufficiency.
Polk RE; Sica DA; Kerkering TM; Kline BJ; Patterson PM; Baggett JW
Antimicrob Agents Chemother; 1984 Sep; 26(3):322-7. PubMed ID: 6095752
[TBL] [Abstract][Full Text] [Related]
3. Elimination kinetics of cefotaxime and desacetyl cefotaxime in patients with renal insufficiency and during hemodialysis.
Ohkawa M; Okasho A; Motoi I; Tokunaga S; Shoda R; Kawaguchi S; Sawaki M; Shimamura M; Hirano S; Kuroda K; Awazu S
Chemotherapy; 1983; 29(1):4-12. PubMed ID: 6299656
[TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetics of ceftriaxone in subjects with renal insufficiency.
Kowalsky SF; Echols RM; Parker MA
Clin Pharm; 1985; 4(2):177-81. PubMed ID: 3987216
[TBL] [Abstract][Full Text] [Related]
5. Pharmacokinetics of cefotaxime and its active metabolite in children with renal dysfunction.
Paap CM; Nahata MC; Mentser MA; Mahan JD; Puri SK; Hubbard JW
Antimicrob Agents Chemother; 1991 Sep; 35(9):1879-83. PubMed ID: 1952862
[TBL] [Abstract][Full Text] [Related]
6. The pharmacokinetics of cefotaxime and its metabolites in subjects with normal and impaired renal function.
Ings RM; Fillastre JP; Godin M; Leroy A; Humbert G
Rev Infect Dis; 1982; 4 Suppl():S379-91. PubMed ID: 6294787
[TBL] [Abstract][Full Text] [Related]
7. Cefonicid kinetics in subjects with normal and impaired renal function.
Blair AD; Maxwell BM; Forland SC; Jacob L; Cutler RE
Clin Pharmacol Ther; 1984 Jun; 35(6):798-803. PubMed ID: 6734031
[TBL] [Abstract][Full Text] [Related]
8. Pharmacokinetics of intravenous and intraperitoneal cefotaxime in chronic ambulatory peritoneal dialysis.
Albin HC; Demotes-Mainard FM; Bouchet JL; Vincon GA; Martin-Dupont C
Clin Pharmacol Ther; 1985 Sep; 38(3):285-9. PubMed ID: 4028623
[TBL] [Abstract][Full Text] [Related]
9. Doses of antibiotic in patients with renal insufficiency.
Ohkawa M; Kuroda K
Clin Ther; 1981; 4 Suppl A():124-32. PubMed ID: 6275994
[TBL] [Abstract][Full Text] [Related]
10. Pharmacokinetics of ampicillin (2.0 grams) and sulbactam (1.0 gram) coadministered to subjects with normal and abnormal renal function and with end-stage renal disease on hemodialysis.
Blum RA; Kohli RK; Harrison NJ; Schentag JJ
Antimicrob Agents Chemother; 1989 Sep; 33(9):1470-6. PubMed ID: 2817847
[TBL] [Abstract][Full Text] [Related]
11. Pharmacokinetics of carumonam in patients with renal insufficiency.
Horber F; Egger HJ; Weidekamm E; Dubach UC; Frey FJ; Probst PJ; Stoeckel K
Antimicrob Agents Chemother; 1986 Jan; 29(1):116-21. PubMed ID: 3729324
[TBL] [Abstract][Full Text] [Related]
12. [Pharmacokinetics of cefotaxime in patients with chronic renal impairment (author's transl)].
Fillastre JP; Ings RM; Leroy A; Humbert G; Godin M
Nouv Presse Med; 1981 Feb; 10(8):574-9. PubMed ID: 6259595
[TBL] [Abstract][Full Text] [Related]
13. Influence of coadministration on the pharmacokinetics of mezlocillin and cefotaxime in healthy volunteers and in patients with renal failure.
Rodondi LC; Flaherty JF; Schoenfeld P; Barriere SL; Gambertoglio JG
Clin Pharmacol Ther; 1989 May; 45(5):527-34. PubMed ID: 2721108
[TBL] [Abstract][Full Text] [Related]
14. Disposition of famotidine in renal insufficiency.
Halstenson CE; Abraham PA; Opsahl JA; Chremos AN; Keane WF; Matzke GR
J Clin Pharmacol; 1987 Oct; 27(10):782-7. PubMed ID: 3429684
[TBL] [Abstract][Full Text] [Related]
15. Elimination kinetics of ceftizoxime in humans with and without renal insufficiency.
Ohkawa M; Okasho A; Sugata T; Kuroda K
Antimicrob Agents Chemother; 1982 Aug; 22(2):308-11. PubMed ID: 6100425
[TBL] [Abstract][Full Text] [Related]
16. Disposition of cefpodoxime proxetil in healthy volunteers and patients with impaired renal function.
St Peter JV; Borin MT; Hughes GS; Kelloway JS; Shapiro BE; Halstenson CE
Antimicrob Agents Chemother; 1992 Jan; 36(1):126-31. PubMed ID: 1590677
[TBL] [Abstract][Full Text] [Related]
17. Pharmacokinetics of cefotiam in patients with impaired renal function and in those undergoing hemodialysis.
Konishi K; Ozawa Y
Antimicrob Agents Chemother; 1984 Nov; 26(5):647-51. PubMed ID: 6097172
[TBL] [Abstract][Full Text] [Related]
18. Clinical pharmacokinetics of cefotaxime in patients with normal and reduced renal function.
Doluisio JT
Rev Infect Dis; 1982; 4 Suppl():S333-45. PubMed ID: 6294782
[TBL] [Abstract][Full Text] [Related]
19. Pharmacology of cefotaxime and its desacetyl metabolite in renal and hepatic disease.
Wise R; Wright N; Wills PJ
Antimicrob Agents Chemother; 1981 Apr; 19(4):526-31. PubMed ID: 6264849
[TBL] [Abstract][Full Text] [Related]
20. Pharmacokinetics of ceftibuten-cis and its trans metabolite in healthy volunteers and in patients with chronic renal insufficiency.
Kelloway JS; Awni WM; Lin CC; Lim J; Affrime MB; Keane WF; Matzke GR; Halstenson CE
Antimicrob Agents Chemother; 1991 Nov; 35(11):2267-74. PubMed ID: 1803999
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
